GlobeNewswire
Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer
📈
AI Sentiment
Highly Positive
9/10
- Home
- MIST
as of 02-13-2026 3:43pm EST
$1.70
$0.02
-1.45%
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
| Founded: | 2003 | Country: | Canada |
| Employees: | N/A | City: | MONTREAL |
| Market Cap: | 176.3M | IPO Year: | N/A |
| Target Price: | $8.50 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.63 - $3.06 | Next Earning Date: | 03-12-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -43150000.0 | FCF Growth: | N/A |
AI-Powered MIST Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 76.77%
76.77%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Milestone Pharmaceuticals Inc. (MIST)
Muller Lorenz
Sell
Chief Commercial Officer
MIST Jan 26, 2026
Avg Cost/Share
$1.93
Shares
11,180
Total Value
$21,577.40
Owned After
205,406
SEC Form 4
Bharucha David
Sell
Chief Medical Officer
MIST Jan 26, 2026
Avg Cost/Share
$1.93
Shares
12,245
Total Value
$23,632.85
Owned After
113,181
SEC Form 4
Oliveto Joseph
Sell
President and CEO
MIST Jan 26, 2026
Avg Cost/Share
$1.93
Shares
34,523
Total Value
$66,629.39
Owned After
482,744
SEC Form 4
Nelson Jeffrey Edward
Sell
Chief Operating Officer
MIST Jan 26, 2026
Avg Cost/Share
$1.93
Shares
12,245
Total Value
$23,632.85
Owned After
49,848
SEC Form 4
Hasija Amit
Sell
CFO & EVP of Corp. Development
MIST Jan 26, 2026
Avg Cost/Share
$1.93
Shares
12,245
Total Value
$23,632.85
Owned After
99,848
SEC Form 4
Oliveto Joseph
Sell
President and CEO
MIST Jan 8, 2026
Avg Cost/Share
$2.25
Shares
43,000
Total Value
$96,750.00
Owned After
482,744
SEC Form 4
Oliveto Joseph
Sell
President and CEO
MIST Jan 7, 2026
Avg Cost/Share
$2.25
Shares
500
Total Value
$1,125.00
Owned After
482,744
SEC Form 4
Muller Lorenz
Sell
Chief Commercial Officer
MIST Dec 15, 2025
Avg Cost/Share
$2.32
Shares
53,566
Total Value
$124,273.12
Owned After
205,406
SEC Form 4
Bharucha David
Sell
Chief Medical Officer
MIST Dec 15, 2025
Avg Cost/Share
$2.32
Shares
58,007
Total Value
$134,576.24
Owned After
113,181
SEC Form 4
Oliveto Joseph
Sell
President and CEO
MIST Dec 15, 2025
Avg Cost/Share
$2.32
Shares
133,054
Total Value
$308,685.28
Owned After
482,744
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Muller Lorenz | MIST | Chief Commercial Officer | Jan 26, 2026 | Sell | $1.93 | 11,180 | $21,577.40 | 205,406 | |
| Bharucha David | MIST | Chief Medical Officer | Jan 26, 2026 | Sell | $1.93 | 12,245 | $23,632.85 | 113,181 | |
| Oliveto Joseph | MIST | President and CEO | Jan 26, 2026 | Sell | $1.93 | 34,523 | $66,629.39 | 482,744 | |
| Nelson Jeffrey Edward | MIST | Chief Operating Officer | Jan 26, 2026 | Sell | $1.93 | 12,245 | $23,632.85 | 49,848 | |
| Hasija Amit | MIST | CFO & EVP of Corp. Development | Jan 26, 2026 | Sell | $1.93 | 12,245 | $23,632.85 | 99,848 | |
| Oliveto Joseph | MIST | President and CEO | Jan 8, 2026 | Sell | $2.25 | 43,000 | $96,750.00 | 482,744 | |
| Oliveto Joseph | MIST | President and CEO | Jan 7, 2026 | Sell | $2.25 | 500 | $1,125.00 | 482,744 | |
| Muller Lorenz | MIST | Chief Commercial Officer | Dec 15, 2025 | Sell | $2.32 | 53,566 | $124,273.12 | 205,406 | |
| Bharucha David | MIST | Chief Medical Officer | Dec 15, 2025 | Sell | $2.32 | 58,007 | $134,576.24 | 113,181 | |
| Oliveto Joseph | MIST | President and CEO | Dec 15, 2025 | Sell | $2.32 | 133,054 | $308,685.28 | 482,744 |
Latest Milestone Pharmaceuticals Inc. News
MIST Breaking Stock News: Dive into MIST Ticker-Specific Updates for Smart Investing
Compare MIST vs Leading Stocks
See how MIST stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MIST Milestone Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.